| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Natsumi Furuta, Kunihiko Ishizawa, Makoto Shibata, Setsuki Tsukagoshi, Shun Nagamine, Kouki Makioka, Yukio Fujita, Masaki Ikeda, Shunsuke Yoshimura, Masakatsu Motomura, Koichi Okamoto, Yoshio Iked. Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis. Internal medicine (Tokyo, Japan). vol 54. issue 19. 2016-07-04. PMID:26424311. |
we herein investigated the clinical features of three patients with anti-muscle-specific tyrosine kinase (musk) antibody-positive myasthenia gravis (mg), which was initially difficult to distinguish from amyotrophic lateral sclerosis (als). |
2016-07-04 |
2023-08-13 |
Not clear |
| Maartje G Huijbers, Anna-Fleur D Vink, Erik H Niks, Ruben H Westhuis, Erik W van Zwet, Robert H de Meel, Ricardo Rojas-García, Jordi Díaz-Manera, Jan B Kuks, Rinse Klooster, Kirsten Straasheijm, Amelia Evoli, Isabel Illa, Silvère M van der Maarel, Jan J Verschuure. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity. Journal of neuroimmunology. vol 291. 2016-06-20. PMID:26857500. |
longitudinal epitope mapping in musk myasthenia gravis: implications for disease severity. |
2016-06-20 |
2023-08-13 |
Not clear |
| Maartje G Huijbers, Anna-Fleur D Vink, Erik H Niks, Ruben H Westhuis, Erik W van Zwet, Robert H de Meel, Ricardo Rojas-García, Jordi Díaz-Manera, Jan B Kuks, Rinse Klooster, Kirsten Straasheijm, Amelia Evoli, Isabel Illa, Silvère M van der Maarel, Jan J Verschuure. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity. Journal of neuroimmunology. vol 291. 2016-06-20. PMID:26857500. |
muscle weakness in musk myasthenia gravis (mg) is caused predominantly by igg4 antibodies which block musk signalling and destabilize neuromuscular junctions. |
2016-06-20 |
2023-08-13 |
Not clear |
| Rongbo Chen, Siqia Chen, Juan Liao, Xiaopu Chen, Xiaoling X. The mechanism of acetylcholine receptor in binding MuSK in myasthenia gravis and the role of HSP90 molecular chaperone. American journal of translational research. vol 8. issue 4. 2016-05-17. PMID:27186300. |
the mechanism of acetylcholine receptor in binding musk in myasthenia gravis and the role of hsp90 molecular chaperone. |
2016-05-17 |
2023-08-13 |
Not clear |
| Rongbo Chen, Siqia Chen, Juan Liao, Xiaopu Chen, Xiaoling X. The mechanism of acetylcholine receptor in binding MuSK in myasthenia gravis and the role of HSP90 molecular chaperone. American journal of translational research. vol 8. issue 4. 2016-05-17. PMID:27186300. |
a total of 38 myasthenia gravis patients and 27 healthy controls were included in this study for the detection of the expression of musk using immunofluorescent method. |
2016-05-17 |
2023-08-13 |
Not clear |
| Rongbo Chen, Siqia Chen, Juan Liao, Xiaopu Chen, Xiaoling X. The mechanism of acetylcholine receptor in binding MuSK in myasthenia gravis and the role of HSP90 molecular chaperone. American journal of translational research. vol 8. issue 4. 2016-05-17. PMID:27186300. |
in myasthenia gravis patients, musk was co-localized with acetylcholine at the postsynaptic membrane. |
2016-05-17 |
2023-08-13 |
Not clear |
| Rongbo Chen, Siqia Chen, Juan Liao, Xiaopu Chen, Xiaoling X. The mechanism of acetylcholine receptor in binding MuSK in myasthenia gravis and the role of HSP90 molecular chaperone. American journal of translational research. vol 8. issue 4. 2016-05-17. PMID:27186300. |
in conclusion, musk was co-localized with acetylcholine in myasthenia gravis patients, with elevated expression. |
2016-05-17 |
2023-08-13 |
Not clear |
| b' Ana V Nikoli\\xc4\\x87, Goran G Ba\\xc4\\x8di\\xc4\\x87, Marko \\xc5\\xbd Dakovi\\xc4\\x87, Slobodan \\xc4\\x90 Lavrni\\xc4\\x87, Vidosava M Rako\\xc4\\x8devi\\xc4\\x87 Stojanovi\\xc4\\x87, Ivana Z Basta, Dragana V Lavrni\\xc4\\x8. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis. Acta neurologica Belgica. vol 115. issue 3. 2016-05-12. PMID:25253293.' |
myopathy, muscle atrophy and tongue lipid composition in musk myasthenia gravis. |
2016-05-12 |
2023-08-13 |
Not clear |
| b' Ana V Nikoli\\xc4\\x87, Goran G Ba\\xc4\\x8di\\xc4\\x87, Marko \\xc5\\xbd Dakovi\\xc4\\x87, Slobodan \\xc4\\x90 Lavrni\\xc4\\x87, Vidosava M Rako\\xc4\\x8devi\\xc4\\x87 Stojanovi\\xc4\\x87, Ivana Z Basta, Dragana V Lavrni\\xc4\\x8. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis. Acta neurologica Belgica. vol 115. issue 3. 2016-05-12. PMID:25253293.' |
myasthenia gravis (mg) associated with anti-muscle-specific tyrosine kinase (musk) antibodies differs in many aspects from typical presentation of acetylcholine receptor (achr)-positive mg. myopathy and muscle atrophy are observed in musk-positive mg patients, unlike achr-positive patients with mg. that is why the aim of this study was to assess the presence of myopathy and muscle atrophy as well as the tongue lipid composition in our cohort of musk-positive mg patients. |
2016-05-12 |
2023-08-13 |
Not clear |
| Mariapaola Marino, Flavia Scuderi, Daniela Samengo, Giorgia Saltelli, Maria Teresa Maiuri, Chengyong Shen, Lin Mei, Mario Sabatelli, Giovambattista Pani, Giovanni Antonini, Amelia Evoli, Emanuela Bartoccion. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis. PloS one. vol 10. issue 8. 2016-05-10. PMID:26284792. |
myasthenia gravis (mg) is an autoimmune disease in which 90% of patients have autoantibodies against the muscle nicotinic acetylcholine receptor (achr), while autoantibodies to muscle-specific tyrosine kinase (musk) have been detected in half (5%) of the remaining 10%. |
2016-05-10 |
2023-08-13 |
Not clear |
| Joanne Ban, William D Phillip. Mouse models of myasthenia gravis. Current pharmaceutical design. vol 21. issue 18. 2016-05-09. PMID:25777761. |
recently, autoantibodies against lrp4 (another component of the musk signaling complex in the postsynaptic membrane) were identified as the likely cause of myasthenia gravis in some patients. |
2016-05-09 |
2023-08-13 |
mouse |
| Karthik Ragunathan, Bandana Pathak, Kumud Daha. MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient. Journal of neurology. vol 262. issue 3. 2016-02-29. PMID:25588730. |
musk myasthenia gravis as a manifestation of immune restoration disease in an hiv-positive patient. |
2016-02-29 |
2023-08-13 |
Not clear |
| Vishwendra Patel, Anne Oh, Antanina Voit, Lester G Sultatos, Gopal J Babu, Brenda A Wilson, Mengfei Ho, Joseph J McArdl. Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis. PloS one. vol 9. issue 12. 2016-02-22. PMID:25438154. |
altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental musk myasthenia gravis. |
2016-02-22 |
2023-08-13 |
mouse |
| Vishwendra Patel, Anne Oh, Antanina Voit, Lester G Sultatos, Gopal J Babu, Brenda A Wilson, Mengfei Ho, Joseph J McArdl. Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis. PloS one. vol 9. issue 12. 2016-02-22. PMID:25438154. |
recent studies demonstrate reduced motor-nerve function during autoimmune muscle-specific tyrosine kinase (musk) myasthenia gravis (mg). |
2016-02-22 |
2023-08-13 |
mouse |
| Vuslat Yilmaz, Piraye Oflazer, Fikret Aysal, Yeşim G Parman, Haner Direskeneli, Feza Deymeer, Güher Saruhan-Direskenel. B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis. Autoimmunity. vol 48. issue 4. 2016-02-03. PMID:25518708. |
b cells from myasthenia gravis (mg) patients with autoantibodies (aab) against acetylcholine receptor (achr), muscle-specific kinase (musk) or with no detectable aab were investigated as cytokine producing cells in this study. |
2016-02-03 |
2023-08-13 |
Not clear |
| Marcus Magnussen, Ioannis Karakis, Taylor B Harriso. The Myotonic Plot Thickens: Electrical Myotonia in Antimuscle-Specific Kinase Myasthenia Gravis. Case reports in neurological medicine. vol 2015. 2016-01-15. PMID:26770848. |
yet, electrical myotonia in myasthenia gravis associated with antibodies against muscle-specific tyrosine kinase (musk) has not been previously reported. |
2016-01-15 |
2023-08-13 |
Not clear |
| Vuslat Yilmaz, Piraye Oflazer, Fikret Aysal, Hacer Durmus, Kostas Poulas, Sibel P Yentur, Yesim Gulsen-Parman, Socrates Tzartos, Alexander Marx, Erdem Tuzun, Feza Deymeer, Güher Saruhan-Direskenel. Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. PloS one. vol 10. issue 4. 2016-01-13. PMID:25893403. |
differential cytokine changes in patients with myasthenia gravis with antibodies against achr and musk. |
2016-01-13 |
2023-08-13 |
Not clear |
| Nazanin Ghazanfari, Erna L T B Linsao, Sofie Trajanovska, Marco Morsch, Paul Gregorevic, Simon X Liang, Stephen W Reddel, William D Phillip. Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis. Physiological reports. vol 3. issue 12. 2015-12-24. PMID:26702075. |
forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of musk myasthenia gravis. |
2015-12-24 |
2023-08-13 |
mouse |
| Nazanin Ghazanfari, Erna L T B Linsao, Sofie Trajanovska, Marco Morsch, Paul Gregorevic, Simon X Liang, Stephen W Reddel, William D Phillip. Forced expression of muscle specific kinase slows postsynaptic acetylcholine receptor loss in a mouse model of MuSK myasthenia gravis. Physiological reports. vol 3. issue 12. 2015-12-24. PMID:26702075. |
we investigated the influence of postsynaptic tyrosine kinase signaling in a mouse model of muscle-specific kinase (musk) myasthenia gravis (mg). |
2015-12-24 |
2023-08-13 |
mouse |
| Nils Erik Gilhus, Jan J Verschuure. Myasthenia gravis: subgroup classification and therapeutic strategies. The Lancet. Neurology. vol 14. issue 10. 2015-12-22. PMID:26376969. |
myasthenia gravis is an autoimmune disease that is characterised by muscle weakness and fatigue, is b-cell mediated, and is associated with antibodies directed against the acetylcholine receptor, muscle-specific kinase (musk), lipoprotein-related protein 4 (lrp4), or agrin in the postsynaptic membrane at the neuromuscular junction. |
2015-12-22 |
2023-08-13 |
Not clear |